As pediatric hospitals fill up with young children sickened by respiratory syncytial virus, doctors are worried that older adults will be the next wave to become seriously ill.
Lead author Dr. Naveed Janjua said the findings related to second doses for both vaccines show men between the ages of 18 and 29 are most at risk of myocarditis if they received Moderna's COVID-19 vaccine.
Study determines how many patients hospitalized with COVID-19 had contraindications to nirmatrelvir–ritonavir and would have required an alternate outpatient treatment.
Having previously updated the risks specified on the product monograph for one type of Janus Kinase inhibitor, Health Canada now says it can't rule out similar risks for other types.
Pfizer executives said the U.S. commercial pricing for adult doses could start early next year, depending on when the government phases out its program of buying and distributing the shots.
